These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491 [TBL] [Abstract][Full Text] [Related]
33. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques. Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476 [TBL] [Abstract][Full Text] [Related]
34. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. Parren PW; Marx PA; Hessell AJ; Luckay A; Harouse J; Cheng-Mayer C; Moore JP; Burton DR J Virol; 2001 Sep; 75(17):8340-7. PubMed ID: 11483779 [TBL] [Abstract][Full Text] [Related]
35. Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains. Shingai M; Donau OK; Schmidt SD; Gautam R; Plishka RJ; Buckler-White A; Sadjadpour R; Lee WR; LaBranche CC; Montefiori DC; Mascola JR; Nishimura Y; Martin MA Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19769-74. PubMed ID: 23129652 [TBL] [Abstract][Full Text] [Related]
36. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230 [TBL] [Abstract][Full Text] [Related]
37. Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodies. Hora B; Li H; Shen X; Martin M; Chen Y; Berry M; Evangelous T; Macintyre AN; Arus-Altuz A; Wang S; Singh A; Zhao C; De Naeyer N; DeMarco T; Kuykendall C; Gurley T; Saunders KO; Denny T; Moody MA; Misamore J; Lewis MG; Wiehe K; Cain DW; Montefiori DC; Shaw GM; Williams WB Cell Rep; 2023 Mar; 42(3):112255. PubMed ID: 36924501 [TBL] [Abstract][Full Text] [Related]
38. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge. Cox JH; Ferrari MG; Earl P; Lane JR; Jagodzinski LL; Polonis VR; Kuta EG; Boyer JD; Ratto-Kim S; Eller LA; Pham DT; Hart L; Montefiori D; Ferrari G; Parrish S; Weiner DB; Moss B; Kim JH; Birx D; VanCott TC Vaccine; 2012 Feb; 30(10):1830-40. PubMed ID: 22234262 [TBL] [Abstract][Full Text] [Related]